Nixon, Douglas

Publications

Sort by

Co-Author Network

selected publications

Distinct Tissue-Dependent Composition and Gene Expression of Human Fetal Innate Lymphoid Cells. European journal of immunology. 2024 Academic Article GET IT
Endogenous Retroelement Expression in Modeled Airway Epithelial Repair. Microbes and infection. 2024 Academic Article GET IT
A model of proximate protection against pathogenic infection through shared immunity. mBio. 2024 Academic Article GET IT
A Transcriptional Signature of Induced Neurons Differentiates Virologically Suppressed People Living With HIV from People Without HIV. 2024 GET IT
Ancient viral DNA in the human genome linked to neurodegenerative diseases. Brain, behavior, and immunity. 2024 Academic Article GET IT
Silencing the transcriptionally active HIV reservoir to improve treatment outcomes. Nature microbiology. 2024 Academic Article GET IT
Retro-age: A unique epigenetic biomarker of aging captured by DNA methylation states of retroelements. Aging cell. 2024 Academic Article GET IT
Integrating human endogenous retroviruses into transcriptome-wide association studies highlights novel risk factors for major psychiatric conditions. Nature communications. 2024 Academic Article GET IT
Endogenous retroelement expression in the gut microenvironment of people living with HIV-1. EBioMedicine. 2024 Academic Article GET IT
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science (New York, N.Y.). 2024 Academic Article GET IT
HIV-1 Mediated Cortical Actin Disruption Mirrors ARP2/3 Defects Found in Primary T Cell Immunodeficiencies. 2024 GET IT
Ribosomal profiling of human endogenous retroviruses in healthy tissues. BMC genomics. 2024 Review GET IT
A single-cell transposable element atlas of human cell identity. 2023 GET IT
The brain-liver cholinergic anti-inflammatory pathway and viral infections. Bioelectronic medicine. 2023 Review GET IT
Transposable elements may enhance antiviral resistance in HIV-1 elite controllers. 2023 GET IT
Retroelement-Age Clocks: Epigenetic Age Captured by Human Endogenous Retrovirus and LINE-1 DNA methylation states. 2023 GET IT
HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing. Viruses. 2023 Academic Article GET IT
Activation of human endogenous retroviruses and its physiological consequences. Nature reviews. Molecular cell biology. 2023 Review GET IT
A History and Atlas of the Human CD4⁺ T Helper Cell. Biomedicines. 2023 Review GET IT
Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation. mBio. 2023 Academic Article GET IT
Transposable elements and Alzheimer's disease pathogenesis. Trends in neurosciences. 2022 Academic Article GET IT
HIV-1 replication and latency are balanced by mTOR-driven cell metabolism. Frontiers in cellular and infection microbiology. 2022 Review GET IT
A field guide to endogenous retrovirus regulatory networks. Molecular cell. 2022 Article GET IT
Transcriptome-wide association study of HIV-1 acquisition identifies HERC1 as a susceptibility gene. iScience. 2022 Academic Article GET IT
Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression. Viruses. 2022 Academic Article GET IT
Times cited: 4
Specific human endogenous retroviruses predict metastatic potential in uveal melanoma. JCI insight. 2022 Academic Article GET IT
Times cited: 8
Booster vaccines for COVID-19 vaccine breakthrough cases?. Lancet (London, England). 2022 Letter GET IT
Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave. Proceedings of the National Academy of Sciences of the United States of America. 2022 Academic Article GET IT
Restriction of HIV-1 infection in sickle cell trait. Blood advances. 2021 Academic Article GET IT
Times cited: 2
SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements. JCI insight. 2021 Academic Article GET IT
Lithium treatment and human hippocampal neurogenesis. Translational psychiatry. 2021 Academic Article GET IT
Extreme immunotherapy: emergency immunology to defeat pandemics. Molecular medicine (Cambridge, Mass.). 2021 Academic Article GET IT
Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry. Molecular medicine (Cambridge, Mass.). 2021 Academic Article GET IT
Genetic risk for severe COVID-19 correlates with lower inflammatory marker levels in a SARS-CoV-2-negative cohort. Clinical & translational immunology. 2021 Academic Article GET IT
Vaccine Breakthrough Infections with SARS-CoV-2 Variants. The New England journal of medicine. 2021 Article GET IT
Times cited: 1
Heterologous vaccine interventions: boosting immunity against future pandemics. Molecular medicine (Cambridge, Mass.). 2021 Information Resource GET IT
Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers. Cancer research. 2021 Academic Article GET IT
Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection. Journal of biomolecular structure & dynamics. 2021 Academic Article GET IT
Times cited: 8
Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany. Human vaccines & immunotherapeutics. 2021 Article GET IT
Times cited: 3
Restriction Factor Expression in Vertically Infected Children Living With HIV-1. The Pediatric infectious disease journal. 2021 Academic Article GET IT
Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil. BMJ open. 2020 Academic Article GET IT
Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study. Frontiers in oncology. 2020 Academic Article GET IT
Times cited: 12
Telomere length and human hippocampal neurogenesis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2020 Academic Article GET IT
Times cited: 25
Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival. Viruses. 2020 Academic Article GET IT
Times cited: 22
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV. Molecular therapy. Methods & clinical development. 2020 Academic Article GET IT
Times cited: 12
Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Journal of medical virology. 2020 Letter GET IT
Times cited: 17
Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target. Viruses. 2020 Review GET IT
Times cited: 55
Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19. AIDS patient care and STDs. 2020 Article GET IT
Times cited: 7
Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. Journal of medical virology. 2020 Article GET IT
Times cited: 133
Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China". Journal of medical virology. 2020 Article GET IT
Times cited: 6
The behavioral, cellular and immune mediators of HIV-1 acquisition: New insights from population genetics. Scientific reports. 2020 Academic Article GET IT
Times cited: 6
Conditional economic incentives to improve HIV prevention. The lancet. HIV. 2020 Article GET IT
HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform. Molecular therapy. Methods & clinical development. 2019 Academic Article GET IT
Times cited: 17
Transcriptomic analysis of human endogenous retroviruses in systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America. 2019 Letter GET IT
Times cited: 11
Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression. PLoS computational biology. 2019 Academic Article GET IT
Times cited: 96
Nef-induced differential gene expression in primary CD4+ T cells following infection with HIV-1 isolates. Virus genes. 2019 Academic Article GET IT
The Psychiatric Risk Gene NT5C2 Regulates Adenosine Monophosphate-Activated Protein Kinase Signaling and Protein Translation in Human Neural Progenitor Cells. Biological psychiatry. 2019 Academic Article GET IT
Times cited: 25
Immune Escape of AML Cells after Transplantation. The New England journal of medicine. 2019 Article GET IT
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. The lancet. HIV. 2019 Conference Paper GET IT
Times cited: 150
The Intimate Relationship Between CD4+ T Cell Morphology and HIV-1 Infection. AIDS research and human retroviruses. 2019 Article GET IT
Allogeneic BK Virus-Specific T Cells for PML. The New England journal of medicine. 2019 Article GET IT
MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection. ASN neuro. 2019 Academic Article GET IT
Times cited: 24
The CD4^-CD8^- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8⁺ MAIT cell pool. Proceedings of the National Academy of Sciences of the United States of America. 2018 Academic Article GET IT
Times cited: 138
Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy. AIDS research and human retroviruses. 2018 Academic Article GET IT
Times cited: 4
Dicer-2 Regulates Resistance and Maintains Homeostasis against Zika Virus Infection in Drosophila. Journal of immunology (Baltimore, Md. : 1950). 2018 Academic Article GET IT
Times cited: 37
Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. 2018 Academic Article GET IT
Times cited: 42
Human interleukin-34-derived macrophages have increased resistance to HIV-1 infection. Cytokine. 2018 Academic Article GET IT
Times cited: 7
HLA-C downregulation by HIV-1 adapts to host HLA genotype. PLoS pathogens. 2018 Academic Article GET IT
Times cited: 21
Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus. AIDS research and human retroviruses. 2018 Academic Article GET IT
Times cited: 20
Biomimetic Placenta-Fetus Model Demonstrating Maternal-Fetal Transmission and Fetal Neural Toxicity of Zika Virus. Annals of biomedical engineering. 2018 Academic Article GET IT
Times cited: 17
Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells. Frontiers in immunology. 2018 Academic Article GET IT
Times cited: 34
TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction. Cancers. 2018 Information Resource GET IT
Times cited: 39
IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF⁺ innate T cells in the human liver. European journal of immunology. 2018 Academic Article GET IT
Times cited: 6
Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation. Frontiers in microbiology. 2018 Academic Article GET IT
Times cited: 14
Allatostatin C modulates nociception and immunity in Drosophila. Scientific reports. 2018 Academic Article GET IT
Times cited: 38
The human IL-15 superagonist ALT-803 directs SIV-specific CD8⁺ T cells into B-cell follicles. Blood advances. 2018 Academic Article GET IT
Times cited: 64
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 153
MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection. PLoS neglected tropical diseases. 2018 Academic Article GET IT
Times cited: 40
Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology. 2017 Academic Article GET IT
Times cited: 22
Enriched environment and stress exposure influence splenic B lymphocyte composition. PloS one. 2017 Academic Article GET IT
Times cited: 27
T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus. Pathogens & immunity. 2017 Academic Article GET IT
Times cited: 19
MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications. PloS one. 2017 Academic Article GET IT
Times cited: 34
Examining HIV Viral Load in a Matched Cohort of HIV Positive Individuals With and Without Psoriasis. Journal of drugs in dermatology : JDD. 2017 Academic Article GET IT
Times cited: 2
A Fas^hi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation. Frontiers in immunology. 2017 Academic Article GET IT
Times cited: 11
HTLV-1 Tax activates HIV-1 transcription in latency models. Virology. 2017 Academic Article GET IT
Times cited: 8
IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI insight. 2017 Academic Article GET IT
Times cited: 11
Immune activation in amniotic fluid from Zika virus-associated microcephaly. Annals of neurology. 2017 Academic Article GET IT
Times cited: 26
p16INK4a Expression and Immunologic Aging in Chronic HIV Infection. PloS one. 2016 Academic Article GET IT
Times cited: 10
Psoriasis risk SNPs and their association with HIV-1 control. Human immunology. 2016 Academic Article GET IT
Times cited: 10
Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. Journal of immunology (Baltimore, Md. : 1950). 2016 Academic Article GET IT
Times cited: 20
Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion. Medicine. 2016 Academic Article GET IT
Times cited: 13
T-cell therapies for HIV: Preclinical successes and current clinical strategies. Cytotherapy. 2016 Information Resource GET IT
Times cited: 33
Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial. Journal of acquired immune deficiency syndromes (1999). 2016 Academic Article GET IT
Times cited: 1
Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection. Mucosal immunology. 2016 Academic Article GET IT
Times cited: 37
Effects of a mindfulness-based weight loss intervention in adults with obesity: A randomized clinical trial. Obesity (Silver Spring, Md.). 2016 Academic Article GET IT
Times cited: 112
Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation. The Journal of infectious diseases. 2015 Academic Article GET IT
Times cited: 9
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial. Proceedings of the National Academy of Sciences of the United States of America. 2015 Academic Article GET IT
Times cited: 13
Modulating APOBEC expression enhances DNA vaccine immunogenicity. Immunology and cell biology. 2015 Academic Article GET IT
Times cited: 5
Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences. PloS one. 2015 Academic Article GET IT
Times cited: 3
Antiviral gene expression in psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2015 Academic Article GET IT
Times cited: 35
Test, treat, and cure. Journal of acquired immune deficiency syndromes (1999). 2015 Article GET IT
Human T-lymphotropic virus 1, breastfeeding, and antiretroviral therapy. AIDS research and human retroviruses. 2014 Article GET IT
Times cited: 1
The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection. Journal of virology. 2014 Academic Article GET IT
Times cited: 46
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis. Journal of translational medicine. 2014 Academic Article GET IT
Times cited: 16
Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo. Journal of virology. 2014 Academic Article GET IT
Times cited: 15
Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells. Journal of immunology (Baltimore, Md. : 1950). 2014 Academic Article GET IT
Times cited: 18
Environmental enrichment alters splenic immune cell composition and enhances secondary influenza vaccine responses in mice. Molecular medicine (Cambridge, Mass.). 2014 Academic Article GET IT
Times cited: 30
Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication. PloS one. 2014 Academic Article GET IT
Times cited: 9
Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine. Mucosal immunology. 2014 Academic Article GET IT
Times cited: 29
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology. 2014 Academic Article GET IT
Times cited: 40
Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease. PloS one. 2014 Academic Article GET IT
Times cited: 39
Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nature communications. 2014 Academic Article GET IT
Times cited: 185
CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology. 2013 Academic Article GET IT
Times cited: 93
Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology. 2013 Academic Article GET IT
Times cited: 76
LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells. Journal of virology. 2013 Academic Article GET IT
Times cited: 50
HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA. HIV medicine. 2013 Academic Article GET IT
Times cited: 8
Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells. Journal of virology. 2013 Academic Article GET IT
Times cited: 30
Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. Journal of leukocyte biology. 2013 Academic Article GET IT
Times cited: 15
Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis. European journal of immunology. 2013 Academic Article GET IT
Times cited: 29
Variability of HIV-1 genomes among children and adolescents from São Paulo, Brazil. PloS one. 2013 Academic Article GET IT
Times cited: 18
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques. Journal of virology. 2013 Academic Article GET IT
Times cited: 4
CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis. PloS one. 2013 Academic Article GET IT
Times cited: 9
Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS neglected tropical diseases. 2013 Academic Article GET IT
Times cited: 25
Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods. Journal of negative results in biomedicine. 2013 Academic Article GET IT
Times cited: 14
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion. AIDS research and human retroviruses. 2013 Academic Article GET IT
Times cited: 12
Skewed distribution of natural killer cells in psoriasis skin lesions. Experimental dermatology. 2013 Article GET IT
Times cited: 36
Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda. PloS one. 2012 Academic Article GET IT
Times cited: 8
Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection. PloS one. 2012 Academic Article GET IT
Times cited: 13
HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. The Journal of clinical investigation. 2012 Academic Article GET IT
Times cited: 74
Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children. PloS one. 2012 Academic Article GET IT
Times cited: 17
Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection. PloS one. 2012 Academic Article GET IT
Times cited: 22
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. PloS one. 2012 Academic Article GET IT
Times cited: 17
Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic. Journal of immunology (Baltimore, Md. : 1950). 2012 Academic Article GET IT
Times cited: 44
HIV-1 Vpu interference with innate cell-mediated immune mechanisms. Current HIV research. 2012 Information Resource GET IT
Times cited: 19
The calm mouse: an animal model of stress reduction. Molecular medicine (Cambridge, Mass.). 2012 Academic Article GET IT
Times cited: 43
Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients. Immunology. 2012 Academic Article GET IT
Times cited: 5
Protective effect of human endogenous retrovirus K dUTPase variants on psoriasis susceptibility. The Journal of investigative dermatology. 2012 Academic Article GET IT
Times cited: 19
Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS genetics. 2012 Academic Article GET IT
Times cited: 61
Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children. PloS one. 2012 Academic Article GET IT
Times cited: 4
Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants. Frontiers in immunology. 2012 Academic Article GET IT
Times cited: 8
Peripheral CD8+ T-cell levels are decreased in atopic wheezing children aged less than 4 years. Journal of investigational allergology & clinical immunology. 2012 Academic Article GET IT
Times cited: 2
Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening. Clinical and vaccine immunology : CVI. 2011 Academic Article GET IT
Times cited: 12
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. Blood. 2011 Academic Article GET IT
Times cited: 34
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proceedings of the National Academy of Sciences of the United States of America. 2011 Academic Article GET IT
Times cited: 666
Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents. PloS one. 2011 Academic Article GET IT
Times cited: 8
Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PloS one. 2011 Academic Article GET IT
Times cited: 43
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. Journal of virology. 2011 Academic Article GET IT
Times cited: 54
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. PLoS neglected tropical diseases. 2011 Academic Article GET IT
Times cited: 24
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection. Scandinavian journal of immunology. 2011 Academic Article GET IT
Times cited: 11
A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males. PloS one. 2010 Academic Article GET IT
Times cited: 45
T cell immunity in acute HIV-1 infection. The Journal of infectious diseases. 2010 Information Resource GET IT
Times cited: 80
Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID). PloS one. 2010 Academic Article GET IT
Times cited: 33
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood. 2010 Academic Article GET IT
Times cited: 589
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. Journal of clinical immunology. 2010 Academic Article GET IT
Times cited: 9
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes. PloS one. 2010 Academic Article GET IT
Times cited: 16
A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties. European journal of immunology. 2010 Academic Article GET IT
Times cited: 15
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption. Journal of acquired immune deficiency syndromes (1999). 2010 Academic Article GET IT
Times cited: 11
Tregs control the development of symptomatic West Nile virus infection in humans and mice. The Journal of clinical investigation. 2009 Academic Article GET IT
Times cited: 191
Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood. 2009 Academic Article GET IT
Times cited: 84
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS (London, England). 2009 Academic Article GET IT
Times cited: 29
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease. Clinical and experimental immunology. 2009 Academic Article GET IT
Times cited: 14
Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens. Molecular biology and evolution. 2009 Academic Article GET IT
Times cited: 33
Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Immunology. 2009 Academic Article GET IT
Times cited: 13
A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PloS one. 2009 Academic Article GET IT
Times cited: 57
Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clinical and vaccine immunology : CVI. 2009 Academic Article GET IT
Times cited: 14
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens. AIDS research and human retroviruses. 2009 Academic Article GET IT
Times cited: 8
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population. European journal of immunology. 2009 Academic Article GET IT
Times cited: 17
Herpes simplex virus and HIV-1: deciphering viral synergy. The Lancet. Infectious diseases. 2009 Article GET IT
Times cited: 5
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science (New York, N.Y.). 2008 Academic Article GET IT
Times cited: 710
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. The Journal of experimental medicine. 2008 Academic Article GET IT
Times cited: 633
Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus. PLoS pathogens. 2008 Academic Article GET IT
Times cited: 13
Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level. Clinical and vaccine immunology : CVI. 2008 Academic Article GET IT
Times cited: 29
The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis. BMC immunology. 2008 Academic Article GET IT
Times cited: 23
Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. AIDS (London, England). 2008 Academic Article GET IT
Times cited: 70
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 2008 Academic Article GET IT
Times cited: 56
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 2008 Academic Article GET IT
Times cited: 22
Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes. Journal of immunology (Baltimore, Md. : 1950). 2008 Academic Article GET IT
Times cited: 47
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. Journal of virology. 2008 Academic Article GET IT
Times cited: 100
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition. PloS one. 2008 Academic Article GET IT
Times cited: 78
Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection. Journal of virology. 2008 Academic Article GET IT
Times cited: 24
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2. The Journal of infectious diseases. 2008 Academic Article GET IT
Times cited: 24
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clinical and vaccine immunology : CVI. 2007 Academic Article GET IT
Times cited: 57
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. Journal of leukocyte biology. 2007 Academic Article GET IT
Times cited: 66
T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS pathogens. 2007 Academic Article GET IT
Times cited: 110
HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts. PloS one. 2007 Academic Article GET IT
Times cited: 25
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. Journal of immunology (Baltimore, Md. : 1950). 2007 Academic Article GET IT
Times cited: 60
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol. Journal of virology. 2007 Academic Article GET IT
Times cited: 12
Rational peptide selection to detect human immunodeficiency virus type 1-specific T-cell responses under resource-limited conditions. Clinical and vaccine immunology : CVI. 2007 Academic Article GET IT
Times cited: 1
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. Journal of virology. 2007 Academic Article GET IT
Times cited: 68
Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. The Journal of infectious diseases. 2007 Academic Article GET IT
Times cited: 46
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PloS one. 2007 Academic Article GET IT
Times cited: 65
Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. Journal of immunology (Baltimore, Md. : 1950). 2007 Academic Article GET IT
Times cited: 124
Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques. Retrovirology. 2006 Academic Article GET IT
Times cited: 14
Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PloS one. 2006 Academic Article GET IT
Times cited: 123
A plea for justice for jailed medical workers. Science (New York, N.Y.). 2006 Article GET IT
Times cited: 4
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells. AIDS research and therapy. 2006 Academic Article GET IT
Regulation of T cell responses in the developing human fetus. Journal of immunology (Baltimore, Md. : 1950). 2006 Academic Article GET IT
Times cited: 177
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Academic Article GET IT
Times cited: 64
CD8 T cell effector maturation in HIV-1-infected children. Virology. 2006 Academic Article GET IT
Times cited: 9
Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS research and human retroviruses. 2006 Academic Article GET IT
Times cited: 37
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption. Journal of clinical immunology. 2006 Academic Article GET IT
Times cited: 17
Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood. 2005 Academic Article GET IT
Times cited: 50
Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus. The Journal of general virology. 2005 Academic Article GET IT
Times cited: 12
Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. Journal of virology. 2005 Academic Article GET IT
Times cited: 179
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients. AIDS (London, England). 2005 Academic Article GET IT
Times cited: 11
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1. The Journal of infectious diseases. 2005 Academic Article GET IT
Times cited: 11
Multidrug-resistant, dual-tropic HIV-1 and rapid progression. Lancet (London, England). 2005 Article GET IT
R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. Journal of virology. 2004 Academic Article GET IT
Times cited: 32
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood. 2004 Academic Article GET IT
Times cited: 24
Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection. Journal of immunology (Baltimore, Md. : 1950). 2004 Academic Article GET IT
Times cited: 56
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3. Journal of acquired immune deficiency syndromes (1999). 2004 Academic Article GET IT
Times cited: 33
Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. The Journal of infectious diseases. 2004 Academic Article GET IT
Times cited: 59
ELISPOT cell rescue. Journal of immunological methods. 2004 Academic Article GET IT
Times cited: 11
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS (London, England). 2004 Academic Article GET IT
Times cited: 96
Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7. Proceedings of the National Academy of Sciences of the United States of America. 2004 Academic Article GET IT
Times cited: 62
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. Journal of virology. 2004 Academic Article GET IT
Times cited: 92
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. Journal of virology. 2004 Academic Article GET IT
Times cited: 408
Poorly soluble peptides can mimic authentic ELISPOT responses. Journal of immunological methods. 2004 Academic Article GET IT
Times cited: 9
Limited magnitude and breadth in the HLA-A2-restricted CD8 T-Cell response to Nef in children with vertically acquired HIV-1 infection. Scandinavian journal of immunology. 2004 Academic Article GET IT
Times cited: 9
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection. Journal of acquired immune deficiency syndromes (1999). 2003 Academic Article GET IT
Times cited: 21
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. Journal of immunological methods. 2003 Academic Article GET IT
Times cited: 156
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression. The Journal of infectious diseases. 2003 Academic Article GET IT
Times cited: 17
Optimization of methods to assess human mucosal T-cell responses to HIV infection. Journal of immunological methods. 2003 Academic Article GET IT
Times cited: 85
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene. Journal of virology. 2003 Academic Article GET IT
Times cited: 43
Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection. Journal of virology. 2003 Academic Article GET IT
Times cited: 71
HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. Journal of immunology (Baltimore, Md. : 1950). 2003 Academic Article GET IT
Times cited: 52
CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets. Journal of immunology (Baltimore, Md. : 1950). 2003 Academic Article GET IT
Times cited: 43
New observations on CD8 cell responses. AIDS (London, England). 2003 Information Resource GET IT
Times cited: 3
Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay. Journal of immunological methods. 2002 Academic Article GET IT
Times cited: 53
Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions. AIDS (London, England). 2002 Academic Article GET IT
Times cited: 49
Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251. AIDS research and human retroviruses. 2002 Academic Article GET IT
Times cited: 5
Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus. Journal of immunology (Baltimore, Md. : 1950). 2002 Academic Article GET IT
Times cited: 30
Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. Journal of virology. 2002 Academic Article GET IT
Times cited: 139
Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women. AIDS research and human retroviruses. 2002 Academic Article GET IT
Times cited: 16
Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. Journal of immunology (Baltimore, Md. : 1950). 2002 Academic Article GET IT
Times cited: 87
Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells. AIDS (London, England). 2002 Academic Article GET IT
Times cited: 36
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. The Journal of infectious diseases. 2002 Academic Article GET IT
Times cited: 64
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection. Journal of virology. 2002 Academic Article GET IT
Times cited: 27
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120. Journal of virology. 2001 Academic Article GET IT
Times cited: 22
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proceedings of the National Academy of Sciences of the United States of America. 2001 Academic Article GET IT
Times cited: 141
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell. 2001 Academic Article GET IT
Times cited: 405
Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. Journal of immunology (Baltimore, Md. : 1950). 2001 Academic Article GET IT
Times cited: 122
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS (London, England). 2001 Academic Article GET IT
Times cited: 173
A simple and rapid magnetic bead separation technique for the isolation of tetramer-positive virus-specific CD8 T cells. AIDS (London, England). 2001 Academic Article GET IT
Times cited: 13
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. Journal of immunological methods. 2001 Academic Article GET IT
Times cited: 133
Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. Virology. 2001 Academic Article GET IT
Times cited: 85
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19. Journal of virology. 2001 Academic Article GET IT
Times cited: 41
Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry. AIDS (London, England). 2000 Academic Article GET IT
Times cited: 35
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection. AIDS (London, England). 2000 Academic Article GET IT
Times cited: 109
Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. AIDS (London, England). 2000 Academic Article GET IT
Times cited: 43
An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Molecular medicine (Cambridge, Mass.). 2000 Academic Article GET IT
Times cited: 29
Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2000 Academic Article GET IT
Times cited: 32
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption. The Journal of infectious diseases. 2000 Academic Article GET IT
Times cited: 104
Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. Journal of immunology (Baltimore, Md. : 1950). 2000 Academic Article GET IT
Times cited: 120
Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus. Virology. 2000 Academic Article GET IT
Times cited: 32
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. The Journal of experimental medicine. 2000 Academic Article GET IT
Times cited: 802
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children. The Journal of infectious diseases. 2000 Academic Article GET IT
Times cited: 32
Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology. 2000 Academic Article GET IT
Times cited: 31
The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy. The Journal of infectious diseases. 2000 Academic Article GET IT
Times cited: 43
Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy. The Journal of infectious diseases. 2000 Academic Article GET IT
Times cited: 70
Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals. AIDS research and human retroviruses. 2000 Academic Article GET IT
Times cited: 33
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine. Virology. 2000 Academic Article GET IT
Times cited: 39
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells. Journal of virology. 2000 Academic Article GET IT
Times cited: 77
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm. AIDS research and human retroviruses. 2000 Academic Article GET IT
Times cited: 30
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. The Journal of clinical investigation. 1999 Academic Article GET IT
Times cited: 216
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children. The Journal of infectious diseases. 1999 Academic Article GET IT
Times cited: 49
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. The Journal of clinical investigation. 1999 Academic Article GET IT
Times cited: 416
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS (London, England). 1999 Academic Article GET IT
Times cited: 194
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. The Journal of infectious diseases. 1999 Academic Article GET IT
Times cited: 159
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. Journal of virology. 1999 Academic Article GET IT
Times cited: 335
Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. Journal of virology. 1999 Academic Article GET IT
Times cited: 96
Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators. The Journal of infectious diseases. 1998 Academic Article GET IT
Times cited: 24
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (New York, N.Y.). 1998 Academic Article GET IT
Times cited: 1233
CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure. Vaccine. 1997 Academic Article GET IT
Times cited: 11
Cytotoxic T cell induction with ratchet peptide libraries. Vaccine. 1996 Academic Article GET IT
Times cited: 2
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine. 1996 Academic Article GET IT
Times cited: 120
Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. European journal of immunology. 1996 Academic Article GET IT
Times cited: 80
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides. Vaccine. 1996 Academic Article GET IT
Times cited: 33
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. European journal of immunology. 1993 Academic Article GET IT
Times cited: 95
Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV. Journal of medical primatology. 1993 Academic Article GET IT
Times cited: 12
Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. AIDS research and human retroviruses. 1992 Academic Article GET IT
Times cited: 15
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991 Academic Article GET IT
Times cited: 858
Vaccines for HIV infected pregnant women?. BMJ (Clinical research ed.). 1991 Article GET IT
Zidovudine after occupational exposure to HIV. BMJ (Clinical research ed.). 1991 Article GET IT
Times cited: 2
An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. AIDS (London, England). 1990 Academic Article GET IT
Times cited: 24
High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. International immunology. 1990 Academic Article GET IT
Times cited: 97
Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. International immunology. 1990 Academic Article GET IT
Times cited: 92
T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins. AIDS (London, England). 1989 Information Resource GET IT
Times cited: 22
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature. 1988 Academic Article GET IT
Times cited: 349
Group-specific component and HIV infection. Lancet (London, England). 1987 Letter GET IT
Times cited: 7
Routine full blood counts as indicators of acute viral infections. Journal of clinical pathology. 1987 Academic Article GET IT
Times cited: 7
Brain Ia antigens have a bone marrow origin. Immunogenetics. 1983 Academic Article GET IT
Times cited: 24
Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes. Immunology. 1981 Academic Article GET IT

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

missing activity Principal Investigator 2021 - 2026
missing activity Principal Investigator 2020 - 2025
missing activity Principal Investigator 2022 - 2024
missing activity Principal Investigator 2021 - 2024

Immunologic control of HIV-1 through combination bNAbs and biologics awarded by National Institute of Allergy & Infectious Diseases Co-Investigator 2019 - 2025

HOPE - HIV Obstruction by Programmed Epigenetics awarded by National Institute of Allergy & Infectious Diseases Co-Principal Investigator 2021 - 2026
REACH: Research Enterprise to Advance a Cure for HIV awarded by National Institute of Allergy & Infectious Diseases Co-Principal Investigator 2021 - 2026
missing activity Co-Principal Investigator 2023 - 2024

more ...

less ...

Background

education and training

M.A., Oxford University (United Kingdom) 91
D.Phil., Oxford University (United Kingdom) 1992
M.B.,B.S., Imperial College London Faculty of Medicine (United Kingdom) 1984
B.Sc., University College, London (United Kingdom) 1981

Contact

full name

Douglas Nixon

primary email

dnixon@med.cornell.edu

VIVO Weill Cornell Medical College

Douglas Nixon Adjunct Professor of Immunology in Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email